Potassium Bicarbonate

Table of contents

  • Brand Names
  • Drug Combinations
  • Chemistry
  • Pharmacologic Category
  • Therapeutic Use
  • Warnings and Precautions
  • Genes that may be involved
  • Drug Interactions
  • Dosage
  • Special Considerations

Brand Names

Europe

Poland: Kalimat Prolongatum, Kalium; UK: Sando-K.

Drug combinations

Potassium Bicarbonate and Potassium Chloride

Potassium Bicarbonate and Potassium Citrate

Other Potassium Bicarbonate combinations: Sodium Bicarbonate

Chemistry

Potassium Bicarbonate: KHCO~3~. Mw: 100.12. Carbonic acid, monopotassium salt; CAS-298-14-6.

Pharmacologic Category

Replacement Preparations; Potassium Supplements. Oral Electrolyte Supplement. (ATC-Code: A12BA04).

Mechanism of action

Therapeutic use

Potassium deficiency, hypokalemia.

Pregnancy and lactiation implications

Unlabeled use

Contraindications

Warnings and precautions

May cause GI upset (e.g. nausea, vomiting, diarrhea, abdominal pain, discomfort) and lead to gastrointestinal ulceration, bleeding, perforation and/or obstruction. Severe hyperkalemia may lead to muscle weakness/paralysis and cardiac conduction abnormalities (e.g. heart block, ventricular arrhythmias, asystole). Changes in serum potassium concentrations can occur during acid/base correction (use with caution in acid/base alterations). Patients may be more susceptible to life-threatening cardiac effects associated with hyper-/hypokalemia (use with caution in cardiovascular disease (e.g. heart failure, cardiac arrhythmias)). Use with caution in disorders or conditions likely to contribute to altered serum potassium and hyperkalemia (e.g. untreated Addison’s disease, heat cramps, severe tissue breakdown from trauma or burns). Use with caution in renal impairment, in digitalized patients (may be more susceptible to potentially life-threatening cardiac effects with rapid changes in serum potassium concentrations), and in patients receiving concomitant medications or therapies which increase potassium (e.g. ACEI, potassium-sparing diuretics, potassium-containing salt substitutes).

Information

Legal

Legal Notice
Privacy Policy
Cookie Policy

Contact

Phone: +34-981-780505
Email: genomicmedicine@wagem.org
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart